A prospective single-center study to evaluate the feasibility of motivation management by wearable fitness devices and smart phone application to influence the clinical manifestation of non-alcoholic fatty liver disease (NAFLD) (OCUN-1) - Usefulness of motivation management for the clinical manifestation of NAFLD

Department of Hepatology, Graduate School of Medicine, Osaka City Universit.0 sites50 target enrollmentFebruary 1, 2019

Overview

Phase: 未知
Intervention: Not specified
Conditions: on-alcoholic fatty liver disease (NAFLD)
Sponsor: Department of Hepatology, Graduate School of Medicine, Osaka City Universit.
Enrollment: 50
Status: Recruiting
Last Updated: 2 years ago

No summary available.

Registry

who.int

Start Date

February 1, 2019

End Date

March 31, 2021

Last Updated

2 years ago

Study Type

Interventional

Sex

All

Sponsor

Department of Hepatology, Graduate School of Medicine, Osaka City Universit.

•1\. HCV antibody and HBs antigen positive patients. 2\. Patients who screened ANA, AMA\-M2 antibody, IgG, IgM, etc. and autoimmune diseases (autoimmune hepatitis, primary biliary cholangitis, etc.) can not be excluded. 3\. Patient with drug\-induced liver injury. 4\. Patients with metabolic liver disease (hemochromatosis, Wilson's disease, alpha\-1 antitrypsin deficiency etc.) 5\. Patients with severe heart disease (unstable angina, acute heart failure, severe valvular disease, severe arrhythmia, active myocarditis, moderate aortic aneurysm, severe hypertension and thrombophlebitis). 6\. Patients with acute systemic disease or fever. 7\. Patients with severe cirrhosis (Child\-Pugh score B or C). 8\. Patients with severe kidney disease (BUN 25 mg / dL or more or serum creatinine 2\.0 mg / dL or more). 9\. Patients who judged unsuitable as subjects by doctors.